Evidence map›Paper›PMID 42270769›Full record

ArticleScientific reports2026

Structural diversity and chemical space analysis of a PROTAC database using unsupervised machine learning.

Ashutosh Kharwar, Alberto Marbán-González, José L Medina-Franco, Carlos A Velázquez-Martínez

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ashutosh KharwarFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, T6G 2E1, Canada. akharwar@ualberta.ca.
Alberto Marbán-GonzálezDIFACQUIM Research Group, Department of Pharmacy, Faculty of Chemistry, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico.
José L Medina-FrancoDIFACQUIM Research Group, Department of Pharmacy, Faculty of Chemistry, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico.
Carlos A Velázquez-MartínezFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, T6G 2E1, Canada. velazque@ualberta.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted protein degradation (TPD) mediated by proteolysis-targeting chimeras (PROTACs) has emerged as a powerful therapeutic strategy, enabling the catalytic and selective elimination of disease-relevant proteins via the ubiquitin-proteasome system. Despite their ability to overcome drug resistance and address traditionally undruggable targets, the structural complexity and vast chemical diversity of PROTACs present challenges for systematic analysis and rational design. Here, we present a systematic unsupervised machine-learning framework that represents the first large-scale similarity-driven clustering and scaffold-centric analysis of the PROTAC chemical space, to comprehensively characterize the structural, functional, and physicochemical landscape of PROTAC molecules and to support data-driven lead optimization and next-generation degrader design. An initial dataset of 9,380 compounds was curated from the publicly available PROTACs Database (PROTAC-DB 3.0), followed by rigorous standardization and filtering, resulting in 6,113 unique, chemically valid compounds. The chemical space was explored using a multi-step computational pipeline involving dimensionality reduction and a comparative evaluation of diverse clustering algorithms. Among the evaluated approaches, a refined clustering strategy demonstrated superior performance in partitioning the dataset into structurally coherent groups. Structural analysis revealed a pronounced convergence around canonical PROTAC architectures, characterized by conserved E3 ligase-binding motifs, diverse target-binding frameworks, and heterogeneous linker designs. Functional group profiling and physicochemical analysis further demonstrated that these compounds predominantly occupy a specialized chemical space beyond traditional drug-like limits, marked by high molecular weight and substantial conformational flexibility. Collectively, these findings provide data-driven design guidance for PROTAC optimization by highlighting frequent scaffold architectures and preferred property ranges, thereby informing the development of next-generation degraders.

Indexed as

Proteolysis Targeting ChimeraUnsupervised Machine LearningCluster AnalysisClustering AlgorithmsHumansProteolysisProteolysis Targeting ChimeraChemical spaceChemoinformaticsDrug discoveryPROTACsUnsupervised learning

Identifiers

PMID42270769
PMCPMC13500699

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.